FDA — authorised 23 July 2018
- Application: NDA210450
- Marketing authorisation holder: ABBVIE
- Status: supplemented
🇺🇸 Orilissa in United States
FDA authorised Orilissa on 23 July 2018
Marketing authorisations
FDA
- Status: approved
Other Other approved in United States
Frequently asked questions
Is Orilissa approved in United States?
Yes. FDA authorised it on 23 July 2018; FDA has authorised it.
Who is the marketing authorisation holder for Orilissa in United States?
ABBVIE holds the US marketing authorisation.